Volume 3, Number 2—June 1997
Rhodococcus equi and Arcanobacterium haemolyticum: Two "Coryneform" Bacteria Increasingly Recognized as Agents of Human Infection
|Period of study (reference)||Number of isolations||Rash||Coinfection||Incidencea (%)||Clinical features (population)|
|1978-80 (16)||16||0||13 (C. diphtheriae, S . pyogenes, E. coli, P. aeruginosa)||NR||Symptomatic throat swabs and pyoderma (Sri Lanka)|
|1981-85 (19)||81b||37||NR||2.0||Symptomatic throat swabs (Sweden)|
|1990-92 (17)||42||17||NR||0.36||Symptomatic throat swabs; 5 cases onospot positive (Ottawa, Canada)|
|1991-92 (42)||19||5||11 (streptococci, groups A, B, G)||0.49||Symptomatic throat swabs, 3922c; (Finland)|
|1992-95 (43)||16||12||5 (streptococci, groups A, B, ß-hemolytic)||0.75||Symptomatic throat swabs, 2121c; (Czech Republic)|
a Incidence refers to the proportion of sore throat cases in each study cited yielding A. haemolyticum.
b1 of 550 asymptomatic specimens yielded A. haemolyticum.
cFigures refer to the total specimens screened.
- Page created: December 21, 2010
- Page last updated: December 21, 2010
- Page last reviewed: December 21, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)